HD-OPM Archive
Topics › Supplements & vitamins

JAMA 2025 trial of high-dose vitamin D in early multiple sclerosis (link only)

Louis Nervegna · Mar 15, 2025 · ♥ 5 reactions · 0 comments · original Facebook post
Supplements & vitamins
AI summary & key facts

Louis shared a link to a JAMA 2025 paper on high-dose cholecalciferol as monotherapy for reducing disease activity in clinically isolated syndrome typical of MS, with no commentary. It is not related to heart disease.

Research cited

#vitamind#jama#vitamins
← newer: Higher Lp(a) is linearly associated with lower risk of fattyolder: Anabolic steroid users had 3x heart attack and 8.9x cardiomy →